Synergy Pharmaceuticals to Present at OctoberINVESTfest 2016
September 23 2016 - 9:30AM
Business Wire
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced the
company will present at the OctoberINVESTfest Conference on
Wednesday, September 28, 2016 at 11:30 a.m. Eastern Time at the New
York Academy of Sciences in New York.
A live webcast of the presentation will be accessible through
the Investor Relations section of the company’s website at
www.synergypharma.com. A replay of the webcast will be available on
Synergy’s website for 60 days following the conference.
About Synergy Pharmaceuticals Inc.
Synergy is a biopharmaceutical company focused on the
development and commercialization of novel gastrointestinal (GI)
therapies. The company has pioneered discovery, research and
development efforts around analogs of uroguanylin, a naturally
occurring human GI peptide, for the treatment of functional GI
disorders and inflammatory bowel disease. Synergy discovered, is
developing and retains 100% worldwide rights to its proprietary
uroguanylin analog technology platform that includes two lead
product candidates – plecanatide and dolcanatide. Plecanatide is
Synergy’s first uroguanylin analog currently being evaluated for
use as a once-daily tablet for chronic idiopathic constipation and
irritable bowel syndrome with constipation. Dolcanatide is
Synergy’s second uroguanylin analog currently being explored for
ulcerative colitis. For more information, please visit
www.synergypharma.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160923005125/en/
Synergy PharmaceuticalsGem Hopkins, 212-584-7610VP, Investor
Relations and Corporate
Communicationsghopkins@synergypharma.com
Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP)
Historical Stock Chart
From Apr 2023 to Apr 2024